New Jersey Center for Biomaterials, Rutgers - The State University of New Jersey, New Brunswick, NJ, 08901, USA.
Universita Cattolica del Sacro Cuore, Clinica Ortopedica, Rome, Italy.
J Mater Sci Mater Med. 2018 Mar 21;29(4):38. doi: 10.1007/s10856-018-6046-4.
Osteoclasts are large multinucleated giant cells that actively resorb bone during the physiological bone turnover (BTO), which is the continuous cycle of bone resorption (by osteoclasts) followed by new bone formation (by osteoblasts). Osteoclasts secrete chemotactic signals to recruit cells for regeneration of vasculature and bone. We hypothesize that a biomaterial that attracts osteoclasts and re-establishes BTO will induce a better healing response than currently used bone graft materials. While the majority of bone regeneration efforts have focused on maximizing bone deposition, the novelty in this approach is the focus on stimulating osteoclastic resorption as the starter for BTO and its concurrent new vascularized bone formation. A biodegradable tyrosine-derived polycarbonate, E1001(1k), was chosen as the polymer base due to its ability to support bone regeneration in vivo. The polymer was functionalized with a RGD peptide or collagen I, or blended with β-tricalcium phosphate. Osteoclast attachment and early stages of active resorption were observed on all substrates. The transparency of E1001(1k) in combination with high resolution confocal imaging enabled visualization of morphological features of osteoclast activation such as the formation of the "actin ring" and the "ruffled border", which previously required destructive forms of imaging such as transmission electron microscopy. The significance of these results is twofold: (1) E1001(1k) is suitable for osteoclast attachment and supports osteoclast maturation, making it a base polymer that can be further modified to optimize stimulation of BTO and (2) the transparency of this polymer makes it a suitable analytical tool for studying osteoclast behavior.
破骨细胞是一种大型多核巨细胞,在生理骨转换 (BTO) 期间积极吸收骨骼,BTO 是骨骼吸收(由破骨细胞)随后新骨形成(由成骨细胞)的连续循环。破骨细胞分泌趋化信号以招募细胞进行血管和骨骼再生。我们假设,一种吸引破骨细胞并重新建立 BTO 的生物材料将比目前使用的骨移植物材料引起更好的愈合反应。虽然大多数骨再生努力都集中在最大限度地增加骨沉积上,但这种方法的新颖之处在于专注于刺激破骨细胞吸收作为 BTO 的启动子及其同时发生的新血管化骨形成。选择可生物降解的酪氨酸衍生聚碳酸酯 E1001(1k) 作为聚合物基质,因为它具有在体内支持骨再生的能力。该聚合物用 RGD 肽或胶原蛋白 I 进行功能化,或与 β-磷酸三钙混合。在所有基质上都观察到破骨细胞附着和早期活跃吸收。E1001(1k) 的透明度与高分辨率共聚焦成像相结合,使我们能够可视化破骨细胞激活的形态特征,例如“肌动蛋白环”和“皱襞边界”的形成,这以前需要破坏性成像形式,例如透射电子显微镜。这些结果的意义有两个方面:(1)E1001(1k) 适合破骨细胞附着并支持破骨细胞成熟,使其成为一种基本聚合物,可以进一步修饰以优化 BTO 的刺激;(2)这种聚合物的透明度使其成为研究破骨细胞行为的合适分析工具。